Final Programme - iuphar

FC09 Inflammation and immunopharmacology:
New tools for old diseases
Mon 326 Neuroprotective effect of pioglitazone on iron-induced neurodegeneration: α-synuclein aggregation
Anya Maan-Yuh Lin, (Taiwan), HJ Yu, SF Fang, PL Chao
Mon 327 Thrombin-induced connective tissue growth factor expression requires c-Src/JAK2/STAT3 signalling
pathway in human lung fibroblasts
Chien-Huang Lin, (Taiwan), H-C Pai, B-C Chen
Mon 328 Molecular mechanisms for ER stress mediated anti-inflammatory actions in macrophages
Wan-Wan Lin, (Taiwan), HR Ho
Mon 329 Inhaled glucocorticoids decrease rapidly bronchial NO flux in childhood asthma
Laura Linkosalo, (Finland), L Lehtimäki, K Holm, M Kaila, J Laitinen, E Moilanen
Mon 330 Establishment of in vitro binding assay of HMGB1 and S100A12 to RAGE: Effects of heparin and
domain peptides on the binding
Rui Liu, (Japan), S Mori, H Wake, J Zhang, K Liu, Y Izushi, M Okamura, HK Takahashi, M Nishibori
Mon 331 Anisodamine augments its cholinergic anti-inflammatory role through potentializing stimulation effect of
IL10 on α7nAChR in sepsis
X Liu, Q Li, A-J Liu, Ding-Feng Su, (PR China)
Mon 332 Effects of anti-TCR antibody on collagen-induced arthritis in DBA/1 mice
Yongxue Liu, (PR China), C Han, Q Wang, Z Gao, M Peng, J Cheng
186 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area